News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Rhythm Biosciences.
RELATED STOCKHEAD STORIES
Health & Biotech
When your guts have gone nuts, who do you call? These ASX stocks are fighting gastrointestinal disease
News
Quarterlies: The best and the worst of today’s 4Cs released on the ASX
Health & Biotech
Cancer Wars Part 2: These are the ASX small cap diagnostics plays that want to conquer cancer
News
Trading Places: Here are this week’s substantial holder movements
Escrow Watch
Escrow Watch: 313 million shares are about to snow onto the ASX
Escrow Watch
Escrow Watch: There’s a doozy coming out this month
Health & Biotech
Rhythm Biosciences’ cheap, effective cancer test could be a godsend to overburdened medical systems
News
Trading Places: More investors follow WiseTech founder into Kyckr
Health & Biotech
No Spin: The health election promises that will affect ASX stocks
News
These are the ASX small caps that might benefit from the Budget
Health & Biotech
Rhythm Biosciences has its reagents, on track to build its new blood test for detecting colon cancer
Health & Biotech
Colon cancer is hitting younger people and obesity may be to blame
Health & Biotech
Could co-marketing be a way for Rhythm Bio to get its test out there?
Health & Biotech
Rhythm Biosciences hits development milestone for its cancer diagnostic
Health & Biotech
Check Up: here’s what’s happening with 140 ASX small cap health stocks
Health & Biotech
Bowel cancer is rising in Asia but Rhythm Bio may be able to help
Health & Biotech